CoChat

MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound

Open access
Timbie, Kelsie F, Afzal, Umara, Date, Abhijit, Zhang, Clark, Song, Ji, Wilson Miller, G., Suk, Jung Soo, Hanes, Justin, Price, Richard J · 2017 · Journal of Controlled Release
Cited by 130

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Systemically administered chemotherapeutic drugs are often ineffective in the treatment of invasive brain tumors due to poor therapeutic index. Within gliomas, despite the presence of heterogeneously leaky microvessels, dense extracellular matrix and high interstitial pressure generate a “blood‐tumor barrier” (BTB), which inhibits drug delivery and distribution. Meanwhile, beyond the contrast MRI‐enhancing edge of the tumor, invasive cancer cells are protected by the intact blood‐brain barrier (BBB). Here, we tested whether brain‐penetrating nanoparticles (BPN) that possess dense surface coatings of polyethylene glycol (PEG) and are loaded with cisplatin (CDDP) could be delivered across both the blood‐tumor and blood‐brain barriers with MR image‐guided focused ultrasound (MRgFUS), and whether this treatment could control glioma growth and invasiveness. To this end, we first established that MRgFUS is capable of significantly enhancing the delivery of ˜ 60 nm fluorescent tracer BPN across the blood‐tumor barrier in both the 9 L (6‐fold improvement) gliosarcoma and invasive F98 (28‐fold improvement) glioma models. Importantly, BPN delivery across the intact BBB, just beyond the tumor edge, was also markedly increased in both tumor models. We then showed that a CDDP loaded BPN formulation (CDDP‐BPN), composed of a blend of polyaspartic acid (PAA) and heavily PEGylated polyaspartic acid (PAA‐PEG), was highly stable, provided extended drug release, and was effective against F98 cells in vitro. These CDDP‐BPN were delivered from the systemic circulation into orthotopic F98 gliomas using MRgFUS, where they elicited a significant reduction in tumor invasiveness and growth, as well as improved animal survival. We conclude that this therapy may offer a powerful new approach for the treatment invasive gliomas, particularly for preventing and controlling recurrence. Graphical abstract Figure. No Caption available.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jconrel.2017.03.017

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 130

Metadata

Authors
Timbie, K. F., Afzal, U., Date, A., Zhang, C., Song, J., Wilson Miller, G., Suk, J. S., Hanes, J., & Price, R. J.
Venue
Journal of Controlled Release
Publisher
Elsevier BV
Published
2017-10
Volume
263
Pages
120-131
ISSN
0168-3659 (ISSN-L)
OpenAlex
W2591624943
Cited by
130
References
8
FWCI
6.05
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound. https://app.cochat.ai/papers/10.1016/j.jconrel.2017.03.017
The paper
Timbie, K. F., Afzal, U., Date, A., Zhang, C., Song, J., Wilson Miller, G., Suk, J. S., Hanes, J., & Price, R. J. (2017). MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2017.03.017

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.